Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "cervical"

56 News Found

Dr. Mansukh Mandaviya chairs celebrations of Ayushman Bharat health and wellness centres
Public Health | April 17, 2022

Dr. Mansukh Mandaviya chairs celebrations of Ayushman Bharat health and wellness centres

Dr. Mansukh Mandaviya launches a quarterly report on AB-HWCs, Guidelines on Human resources for health, Public Health Management Cadre’ Guidance for implementation and Indian Public Health Standards Guidelines; interacts with healthcare workers from across the country


SRV Hospitals and Lokmanya Hospital launch centre for robotic orthopaedics
Hospitals | March 30, 2022

SRV Hospitals and Lokmanya Hospital launch centre for robotic orthopaedics

The SRV LHPL centre of excellence in robotic orthopaedics will be helmed by joint replacement surgeon, Dr Narendra Vaidya


AbbVie to showcase neuroscience portfolio at AAN 2022 annual meeting
Biotech | March 29, 2022

AbbVie to showcase neuroscience portfolio at AAN 2022 annual meeting

AbbVie to present 30 abstracts demonstrating its leadership in neuroscience, including continued migraine treatment research across the spectrum of the disease, commitment to patients with advanced Parkinson's disease, and new studies in spasticity and cervical dystonia


Roche Diagnostics India wins Frost & Sullivan 2021 India leadership award
Medical Device | March 14, 2022

Roche Diagnostics India wins Frost & Sullivan 2021 India leadership award

Its technology-centric solutions enable hospitals to enhance operational efficiency and enable faster clinical decision making


MSD India launches 9-valent Human Papillomavirus (HPV) vaccine, GARDASIL 9
Drug Approval | September 29, 2021

MSD India launches 9-valent Human Papillomavirus (HPV) vaccine, GARDASIL 9

India’s first gender-neutral HPV vaccine to help reduce HPV -related disease burden in Indian girls, women and boys


Biocon and Viatris receive EC approval for Biosimilar Bevacizumab
Biotech | April 28, 2021

Biocon and Viatris receive EC approval for Biosimilar Bevacizumab

The drug is approved for the treatment in metastatic colorectal carcinoma, metastatic breast cancer and ovarian, cervical and renal cancer